Switching Between Biosimilars And Reference Products - Biotechnology

Relevant Publications

Biosimilar in Breast Cancer: A Narrative Review.

Issue Release: 2024

Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort.

Issue Release: 2024

Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study.

Issue Release: 2024

Biosimilars engage in low levels of direct-to-physician marketing relative to reference biologics.

Issue Release: 2023

Investigation of immunogenicity assessment of biosimilar monoclonal antibodies in the United States.

Issue Release: 2023

Assessment of Reported Adverse Events After Interchanging Between TNF-α Inhibitor Biosimilars in the WHO Pharmacovigilance Database.

Issue Release: 2023

Interchangeability of biosimilars: A study of expert views and visions regarding the science and substitution.

Issue Release: 2022

Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective.

Issue Release: 2021

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians.

Issue Release: 2021

An Update Review of Biosimilars of Adalimumab in Psoriasis - Bioequivalence and Interchangeability.

Issue Release: 2021

Safety of switching between rituximab biosimilars in onco-hematology.

Issue Release: 2021

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?

Issue Release: 2021

The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review.

Issue Release: 2020

Biosimilars in Inflammatory Bowel Disease.

Issue Release: 2020

Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.

Issue Release: 2020

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity.

Issue Release: 2020

In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study.

Issue Release: 2020

Are we ready to close the discussion on the interchangeability of biosimilars?

Issue Release: 2019

Prevalence of switching from two anti-TNF biosimilars back to biologic reference products in Germany .

Issue Release: 2019

The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies.

Issue Release: 2018

How Can We Mitigate the Risks Associated with Genetic Research?

How Does Biotechnology Enhance Food Safety?

How Can Biotechnology Combat Climate Change?

What is Gene Therapy?

What are Genome Wide Association Studies (GWAS)?

What Are Genetic Markers?

What are the Core Subjects in Biotechnology Education?

What Are the Benefits of Precision Farming?

What Are Dual-Use Technologies?

How Does Bioaugmentation Work?

Partnered Content Networks

Relevant Topics